Osteoprotegerin: Relationship to Breast Cancer Risk and Prognosis
Osteoprotegerin (OPG) is a secreted member of the Tumor Necrosis Factor (TNF) receptor superfamily (TNFRSF11B), that was first characterized and named for its protective role in bone remodeling. In this context, OPG binds to another TNF superfamily member Receptor Activator of NF-kappaB Ligand (RANK...
Main Authors: | Dirk Geerts, Christina Chopra, Linda Connelly |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.00462/full |
Similar Items
-
Editorial: The Tumor Necrosis Factor Superfamily: An Increasing Role in Breast Cancer
by: Dirk Geerts, et al.
Published: (2020-12-01) -
The Role of Osteoprotegerin and Its Ligands in Vascular Function
by: Luc Rochette, et al.
Published: (2019-02-01) -
Unfractionated Heparin Promotes Osteoclast Formation in Vitro by Inhibiting Osteoprotegerin Activity
by: Binghan Li, et al.
Published: (2016-04-01) -
Evaluation of rs3102735 and rs2073617 Osteoprotegerin Gene Polymorphisms and the Risk of Childhood Acute lymphoblastic Leukemia in Zahedan Southeast Iran
by: Mohammad Hashemi, et al.
Published: (2014-12-01) -
Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-kB/receptor activator of NF-kB ligand/osteoprotegerin (RANK/RANKL/OPG) pathway
by: Xiao-Feng He, et al.
Published: (2017-11-01)